Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey

Arthritis Research and Therapy

Volumn 15, Issue 2, 2013, Pages

  Solomon, Daniel H ^a   Yelin, Edward ^b   Katz, Jeffrey N ^a   Lu, Bing ^a   Shaykevich, Tamara ^a   Ayanian, John Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; AGE; ARTICLE; COMORBIDITY; DRUG USE; EDUCATION; ETHNICITY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; INCOME; INSURANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PROBABILITY; RACE; RHEUMATOID ARTHRITIS; AGED; ARTHRITIS, RHEUMATOID; CLINICAL PRACTICE; COHORT ANALYSIS; HEALTH CARE DISPARITY; INFORMATION PROCESSING; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DATA COLLECTION; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICARE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84875059638     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4201     Document Type: Article

References (22)

1. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008, 59:762-784. 10.1002/art.23721, 18512708.
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69:964-975.
3. Ward MM, Fries JF. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. J Rheumatol 1998, 25:408-416.
4. Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007, 57:928-934. 10.1002/art.22890, 17665462.
5. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005, 53:241-248. 10.1002/art.21077, 15818655.
6. Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, Yazdany J. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in medicare managed care plans. Jama 2011, 305:480-486. 10.1001/jama.2011.67, 3172813, 21285425.
7. Widdifield J, Bernatsky S, Paterson JM, Thorne JC, Cividino A, Pope J, Gunraj N, Bombardier C. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective. Arthritis Care Res (Hoboken) 2010, 63:53-57.
8. Shipton D, Glazier RH, Guan J, Badley EM. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 2004, 42:907-913. 10.1097/01.mlr.0000135810.39691.f6, 15319617.
9. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 2005, 87:1222-1228.
10. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. Jama 1993, 269:2642-2646. 10.1001/jama.1993.03500200056033, 8487447.
11. Kasiske BL, Neylan JF, Riggio RR, Danovitch GM, Kahana L, Alexander SR, White MG. The effect of race on access and outcome in transplantation. N Engl J Med 1991, 324:302-307. 10.1056/NEJM199101313240505, 1898431.
12. Williams RA. Eliminating healthcare disparities in America: beyond the IOM report 2007, Totowa, NJ: Humana Press.
13. Jonk Y, O'Connor H, Schult T, Cutting A, Feldman R, Ripley DC, Dowd B. Using the Medicare Current Beneficiary Survey to conduct research on Medicare-eligible veterans. J Rehabil Res Dev 47:797-813.
14. Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Adler G, Safran DG. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med 2006, 166:1829-1835. 10.1001/archinte.166.17.1829, 17000938.
15. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
16. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, Beckles GL. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 2006, 166:2348-2355. 10.1001/archinte.166.21.2348, 17130388.
17. Booth GL, Hux JE. Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med 2003, 163:101-106. 10.1001/archinte.163.1.101, 12523923.
18. Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, Cohen AS. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985, 28:987-994. 10.1002/art.1780280905, 4038365.
19. Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?. Ann Rheum Dis 2006, 65:1226-1229. 10.1136/ard.2005.051144, 1798297, 16414968.
20. MacLean C, Park G, Traina S, Liu H, Hahn B, Paulus HE, Khan K. Positive predictive value of an administrative database algorithm for the identification of patients with rheumatoid arthritis [abstract]. Arthritis Rheum 2001, 44:S106.
21. Poisal JA. Reporting of drug expenditures in the MCBS. Health Care Financ Rev 2003, 25:23-36.
22. Barton JL, Trupin L, Schillinger D, Gansky SA, Tonner C, Margaretten M, Chernitskiy V, Graf J, Imboden J, Yelin E. Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res (Hoboken) 63:1238-1246.